Adamas announces settlement agreement of previously disclosed class action litigation

Emeryville, calif., nov. 02, 2020 (globe newswire) -- adamas pharmaceuticals, inc. (nasdaq: adms), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced it has signed a memorandum of understanding to settle one of the previously disclosed securities class-action lawsuits, plymouth v. adamas pharmaceuticals, inc., et al., case no. rg19018715, pending in the california superior court for the county of alameda.
ADMS Ratings Summary
ADMS Quant Ranking